Inventaire - your friends and communities are your best library

Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study

author

Elizabeth Streicher

Laura Forsberg White

Robin M. Warren

Mary Kleinman

Karen R Jacobson

Paul van Helden

published in: Clinical Infectious Diseases

date of publication: 2017-06-01

language: English

Cites articles 23

Date

Title

Authors

2016-06-24

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use

Gina Gualano, Fabrizio Palmieri
2016-01-13

Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis

Devinder Kaur, Maha R Farhat, Karen R Jacobson, Molly F Franke
2015-07-28

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis

Michael G Whitfield, Heidi M Soeters, Robin M. Warren, Samantha Leigh Sampson, Elizabeth Streicher, Annelies Van Rie, Paul van Helden
2015-01

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa

Mark Nicol, Gilles Van Cutsem, Jennifer Hughes
2014-11-01

Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa

Gabriel Cohen, Ingrid V Bassett, Farzad Noubary
2014-08-27

Rapid sequencing of the Mycobacterium tuberculosis pncA gene for detection of pyrazinamide susceptibility

Alexander S Pym, Elizabeth Streicher, Robin M. Warren, Paul van Helden
2014-08-16

Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa

Lise Werner
2014-07-08

Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study

James A Seddon
2013-07-24

Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study

Mark Nicol, Keertan Dheda, Heather Zar
2013-03-01

Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa

Marisa Klopper, Elizabeth Streicher, Robin M. Warren, Borna Müller
2013-03-01

Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa

Annelies Van Rie, Kathryn Schnippel, Kate Clouse
2012-12-07

Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence

Molly F Franke, Jennifer Furin, Mercedes C. Becerra
2012

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Dick Menzies, Mario H. Vargas, Helen Cox, Matthew J Strand, Alfredo Ponce-de-Leon, Payam Tabarsi, Rosella Centis, Jerome Robert, Giovanni Sotgiu, Tjip S van der Werf, Giovanni Battista Migliori, Madhukar Pai, Donald A. Enarson, Won-Jung Koh, Carole D Mitnick
2012-10-20

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Laura Via, Cesar Bonilla, Clifton E Barry, Isdore Chola Shamputa
2012-11-08

Can inhA mutation predict ethionamide resistance?
2012-10-18

Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.

Robin M. Warren, Nicolaas C Gey van Pittius, Elizabeth Streicher, Paul van Helden
2011-12-14

Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa

Gian D Van Der Spuy, Elizabeth Streicher, Robin M. Warren, Violet N. Chihota, Borna Müller, Manormoney Pillay, Paul van Helden
2011-07

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

Katharina Kranzer, Linda-Gail Bekker, Mark Nicol, Stephen Lawn, Robin Wood, Monica Vogt
2011-04-18

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Mark Nicol, Helen Cox
2011-08-04

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa

Nicolaas C Gey van Pittius, Elizabeth Streicher, Robin M. Warren, Violet N. Chihota, Borna Müller, Manormoney Pillay, Paul van Helden
2009-09-14

High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene

Françoise Portaels
2008-01-17

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa
1999-10-01

Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media

Article - wd:Q40332311

Welcome to Inventaire

the library of your friends and communities

learn more